FDA 483 - Grand River Aseptic Manufacturing, Inc. - September 19, 2024

An FDA inspection of Grand River Aseptic Manufacturing Inc. in Grand Rapids, MI, identified two significant observations. The firm failed to adequately simulate all manufacturing processing steps during a fill validation study for a syringe filling line. Additionally, unplanned operational activities and interventions were not timely documented in manufacturing batch records.